Fibromyalgia, Red Light Therapy and the Treatment Revenue You Might Be Missing

How whole body photobiomodulation is transforming chronic pain care, and what it could mean for your clinic’s spare room. Fibromyalgia affects an estimated 1 in 20 people in the UK. For many of those living with it, the search for meaningful relief is relentless, and often deeply frustrating. Conventional approaches offer limited results, and patients frequently fall through the gaps of a system that doesn’t quite know what to do with them. 

That’s where you come in...

A growing body of clinical research, including a landmark systematic review published in April 2025, confirms that photobiomodulation therapy (PBMT), more commonly known as red light therapy, offers significant and measurable benefits for fibromyalgia clients. 

• Pain reduction. 

• Better sleep. 

• Improved function. 

• Less reliance on medication. 

At Essence, we’ve seen this first hand. Client feedback has been consistently and compellingly positive, particularly around pain relief and sleep quality. And practitioners who’ve added a red light bed to their clinic are discovering something else: it’s also quietly brilliant for business. 

What Fibromyalgia Actually Is

Fibromyalgia is a chronic central nervous system disorder characterised by widespread musculoskeletal pain, profound fatigue, cognitive difficulties (“fibro fog”), sleep disruption, and heightened sensitivity to pain signals. It’s not “just” pain, it’s a full-body condition rooted in the way the nervous system processes sensation. At a cellular level, fibromyalgia is closely linked to:

• Mitochondrial dysfunction the body’s cells struggle to produce adequate energy (ATP)

• Elevated oxidative stress an imbalance of free radicals that drives inflammation

• Impaired antioxidant defences, including reduced levels of CoQ10

• Dysregulated pain signalling pathways, including heightened sensitivity at nerve endings

• Autonomic nervous system imbalance, contributing to fatigue and sleep disruption

This biological picture matters, because it’s precisely what makes fibromyalgia such a good match for red light therapy. 

The most comprehensive evidence to date comes from a systematic review published in the peer-reviewed journal Applied Sciences (MDPI) in April 2025, registered on the international PROSPERO database. Researchers analysed all available clinical studies on the effectiveness of PBMT for fibromyalgia, evaluating outcomes across pain, physical function, sleep quality, and overall well-being. The review concluded that PBMT “supports the use of photobiomodulation therapy as an adjunctive treatment for fibromyalgia syndrome, promoting its integration into multidisciplinary pain management.”

Crucially, the researchers identified the precise biological mechanisms behind these results. Photobiomodulation works by targeting cytochrome c oxidase (CCO) a key enzyme in the mitochondrial energy production chain. When near-infrared or red light wavelengths interact with CCO, they enhance ATP production, reduce oxidative stress, and modulate gene expression related to pain signalling. In plain English: the light gives cells the energy they need to heal and regulate themselves, reducing the very dysfunction that drives fibromyalgia symptoms. Earlier 

Clinical Trials: Significant Results

The 2025 review builds on a solid foundation of earlier research:

• A 42 person randomised controlled trial found “significant pain reduction and improved quality of life” in fibromyalgia patients, alongside reduced catastrophising and fear of movement.

• A 2019 whole-body photobiomodulation study (De Andrade et al., Lasers in Medical Science) showed reduced pain intensity and tender point count in fibromyalgia patients.

• Trials by Gür et al. (2002) and Armagan et al. (2006) demonstrated significant pain reduction and improved functional outcomes using red and near-infrared light.

• Research has documented pain reductions of 6–8 points on standardised scales, tender point counts dropping from 14 to zero, and significant improvements in Fibromyalgia Impact Questionnaire (FIQ) scores. How the Mechanisms Stack Up

Red light therapy addresses fibromyalgia through multiple pathways simultaneously:

• ATP production: Restores cellular energy, reducing fatigue and supporting healing

• Oxidative stress reduction: Lowers the inflammatory burden that perpetuates pain

• Pain pathway modulation: Reduces nerve hypersensitivity and nociceptive signalling

• Beta-endorphin release: Stimulates the body’s own natural pain-relief system

• Improved microcirculation: Enhances blood flow to muscles and soft tissue

• Neurotransmitter balance: Supports improved sleep quality and mood regulation

• Autonomic nervous system regulation: Reduces hypersensitivity to pain and environmental stressors

A 2025 clinical review confirmed the strongest evidence for photobiomodulation is in fibromyalgia and osteoarthritis-related pain, describing it as offering “a favourable safety profile” compared with pharmaceutical interventions, with no documented drug interactions. 

What This Looks Like in Practice

For clients with fibromyalgia, whole body red light therapy sessions represent something genuinely new: a non-invasive, drug free treatment that doesn’t just mask symptoms but works at a cellular level to address the underlying dysfunction. 

In one of our clinics, Essence Wellness, they have received consistently positive feedback from clients using the red light beds for fibromyalgia and chronic pain, particularly around:

• Reduced pain levels following regular sessions

• Noticeably improved sleep quality

• Greater energy and reduced fatigue

• Improved mood and a sense of overall wellbeing

The experience itself is gentle, restorative and deeply relaxing, something chronically exhausted clients often describe as the first time they’ve genuinely rested in years. “It’s the first thing I’ve tried that’s actually made a difference. My pain levels have reduced significantly and I’m sleeping better than I have in years.”  Essence client feedback

For practitioners, that client experience translates into something important: loyalty. Clients who find meaningful relief come back, consistently, and often long-term. 

The Business Case: That Spare Room Has Potential

Here’s something worth sitting with: fibromyalgia affects roughly 1 in 20 people. That’s a huge chunk of your current client base, and an even broader audience of people still searching for solutions and not finding them in conventional healthcare. They are motivated. They are consistent. And, they want more investment in something that truly helps. 

Revenue Streams Ready for Action  

Implementing a bed for red light therapy consumes little ongoing effort that your team can invest in. When installed, it functions as a semi-passive income source, clients book in, arrive, rest and leave feeling better. The money that flows is generated from regular business transactions. It doesn’t fight for your treatment space; it is supplementary to it. For a clinic with a room, an underused floor space, a quiet corner, the BioNovu red light bed fits neatly into your existing space. The setup is simple and it requires minimal staff involvement.

Who This Reaches  

Beyond fibromyalgia, red light therapy appeals to clients looking for assistance with:  

• Chronic fatigue and ME/CFS  

• Chronic musculoskeletal pain, neck pain and joint conditions  

• Osteoarthritis and mobility issues  

• Post-surgical or injury recovery  

• General well-being: sleep, energy and mood optimisation  

And all of these, have their research base increasing. A 2025 meta-analysis of RCTs found that photobiomodulation was effective treatment for chronic pain such as osteoarthritis and temporomandibular disorders. Systematic reviews have also reported large reductions in neck pain and improvement in functionality. This a treatment modality that’s truly picking up steam in clinical practice, and showing up early puts your clinic ahead of the curve. 

The Investment Makes Sense  

This whole body red light therapy is a growing sector. At BioNovu, we partner with practitioners to bridge the gap. The Bionovu red light bed is designed for clinic practice, client experience is the goal, and is supported by the increasing clinical evidence presented in this article.

In Summary  

Red light therapy isn’t a miracle cure, and we are far from arguing that it is. But for those living with fibromyalgia, the evidence for meaningful, multi-symptom benefit is now strong. And for clinics ready to incorporate it into their roster, the opportunity is visible. Your clients have been seeking such a bed for a while before. Let them locate it with you, if only a little. 

Want to see more about setting a Bionovu red light bed inside your clinic? 

Contact the Bionovu team to talk about your space, your clients and how a red light bed might work for your practice. 

Contact Us

Research References  

Systematic review: MDPI Applied Sciences, April 2025  Effectiveness of Photobiomodulation Therapy in the Management of Fibromyalgia Syndrome (PROSPERO CRD42024626368)  

De Andrade et al. (2019). Whole-body photobiomodulation and fibromyalgia. Gür et al. (2002); Armagan et al. (2006)  Randomised controlled trials, red and near-infrared light, fibromyalgia outcomes. Chow et al. (2014) Low-level laser therapy for chronic neck pain. The Lancet. NCBI/PMC (2025)  Redox reactions in chronic pain: mechanisms and relevance in fibromyalgia.